100 related articles for article (PubMed ID: 33822037)
1. Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
Landmesser U; Lehmann I; Eils R
Eur Heart J; 2021 May; 42(18):1720-1721. PubMed ID: 33822037
[No Abstract] [Full Text] [Related]
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
3. ACEi reduces hypertension-induced hyperinflammation in COVID-19.
Lim GB
Nat Rev Cardiol; 2021 Apr; 18(4):231. PubMed ID: 33462417
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Hyperinflammation: What about Neutrophils?
Didangelos A
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581077
[TBL] [Abstract][Full Text] [Related]
5. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
Cappuccio FP; Siani A
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
[TBL] [Abstract][Full Text] [Related]
6. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?
Xiaoliang Yan ; Jing L; Deng Y
Heart Surg Forum; 2020 Nov; 23(6):E895-E896. PubMed ID: 33253109
[TBL] [Abstract][Full Text] [Related]
8. [COVID-19 and myocardial injury].
Schukraft S; Puricel S; Doll S; Vivekanantham H; Brahim-Mathiron A; Togni M; Cook S; Arroyo D
Rev Med Suisse; 2021 Mar; 17(728):418-423. PubMed ID: 33656293
[TBL] [Abstract][Full Text] [Related]
9. [Impact of cardiovascular metabolic diseases on COVID-19: review of recent progress].
Han T; Yuan H; Ye L; Jiang X; Bai L; Wang C
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):628-632. PubMed ID: 33963726
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular system is at higher risk of affecting by COVID-19.
Nejadghaderi SA; Heidari A; Shakerian N; Saghazadeh A; Rezaei N
Acta Biomed; 2020 Sep; 91(3):e2020018. PubMed ID: 32921715
[TBL] [Abstract][Full Text] [Related]
11. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment].
Schieffer E; Schieffer B; Hilfiker-Kleiner D
Herz; 2021 Mar; 46(2):107-114. PubMed ID: 33394058
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
Bartoloni E; Perricone C; Cafaro G; Gerli R
Cardiovasc Res; 2020 Nov; 116(13):e193-e194. PubMed ID: 32966547
[No Abstract] [Full Text] [Related]
14. Cardiovascular system in the sars-CoV-2: impact of therapies.
Redon J
J Hypertens; 2021 Jul; 39(7):1306-1308. PubMed ID: 34074967
[No Abstract] [Full Text] [Related]
15. Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic.
Narita K; Hoshide S; Tsoi K; Siddique S; Shin J; Chia YC; Tay JC; Teo BW; Turana Y; Chen CH; Cheng HM; Sogunuru GP; Wang TD; Wang JG; Kario K
J Clin Hypertens (Greenwich); 2021 Mar; 23(3):575-583. PubMed ID: 33527663
[TBL] [Abstract][Full Text] [Related]
16. Potential Effects of Coronaviruses on the Cardiovascular System: A Review.
Madjid M; Safavi-Naeini P; Solomon SD; Vardeny O
JAMA Cardiol; 2020 Jul; 5(7):831-840. PubMed ID: 32219363
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
19. [COVID-19 and cardiovascular diseases].
Chazova IE; Mironova OI
Ter Arkh; 2020 Oct; 92(9):4-7. PubMed ID: 33346424
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular manifestations in severe and critical patients with COVID-19.
Chen Q; Xu L; Zhu W; Ge J
Clin Cardiol; 2020 Oct; 43(10):1054. PubMed ID: 32667051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
